These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 17953697

  • 1. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase.
    Chen WT, Hung WC, Kang WY, Huang YC, Chai CY.
    Histopathology; 2007 Dec; 51(6):785-92. PubMed ID: 17953697
    [Abstract] [Full Text] [Related]

  • 2. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS, Carvalho AL, Jeronimo C, Henrique R, Kim MM, Hoque MO, Chang S, Jiang WW, Koch W, Westra W, Sidransky D, Califano J.
    Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.
    Liu XF, Kong FM, Xu Z, Yu SP, Sun FB, Zhang CS, Huang QX, Zhou XT, Song ZW.
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):407-11. PubMed ID: 17690039
    [Abstract] [Full Text] [Related]

  • 9. Death-associated protein kinase promoter hypermethylation in normal human lymphocytes.
    Reddy AN, Jiang WW, Kim M, Benoit N, Taylor R, Clinger J, Sidransky D, Califano JA.
    Cancer Res; 2003 Nov 15; 63(22):7694-8. PubMed ID: 14633692
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers.
    Tada Y, Wada M, Taguchi K, Mochida Y, Kinugawa N, Tsuneyoshi M, Naito S, Kuwano M.
    Cancer Res; 2002 Jul 15; 62(14):4048-53. PubMed ID: 12124340
    [Abstract] [Full Text] [Related]

  • 12. Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer.
    Leung RC, Liu SS, Chan KY, Tam KF, Chan KL, Wong LC, Ngan HY.
    Oncol Rep; 2008 May 15; 19(5):1339-45. PubMed ID: 18425396
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Promoter methylation and down-regulation of DAPK is associated with gastric atrophy.
    Kim WS, Son HJ, Park JO, Song SY, Park C.
    Int J Mol Med; 2003 Dec 15; 12(6):827-30. PubMed ID: 14612952
    [Abstract] [Full Text] [Related]

  • 15. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
    Nakamichi I, Tomita Y, Zhang B, Sugiyama H, Kanakura Y, Fukuhara S, Hino M, Kanamaru A, Ogawa H, Aozasa K.
    Ann Hematol; 2007 Aug 15; 86(8):557-64. PubMed ID: 17508213
    [Abstract] [Full Text] [Related]

  • 16. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.
    Brabender J, Arbab D, Huan X, Vallböhmer D, Grimminger P, Ling F, Neiss S, Bollschweiler E, Schneider PM, Hölscher AH, Metzger R.
    Ann Surg Oncol; 2009 May 15; 16(5):1378-83. PubMed ID: 19224282
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer.
    Sugita H, Iida S, Inokuchi M, Kato K, Ishiguro M, Ishikawa T, Takagi Y, Enjoji M, Yamada H, Uetake H, Kojima K, Sugihara K.
    Oncol Rep; 2011 Feb 15; 25(2):513-8. PubMed ID: 21152877
    [Abstract] [Full Text] [Related]

  • 19. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.
    Schildhaus HU, Kröckel I, Lippert H, Malfertheiner P, Roessner A, Schneider-Stock R.
    Int J Oncol; 2005 Jun 15; 26(6):1493-500. PubMed ID: 15870861
    [Abstract] [Full Text] [Related]

  • 20. Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.
    Jarmalaite S, Jankevicius F, Kurgonaite K, Suziedelis K, Mutanen P, Husgafvel-Pursiainen K.
    Oncology; 2008 Jun 15; 75(3-4):145-51. PubMed ID: 18824877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.